Chinese Medicine for Prevention and Treatment of Irritable Bowel Syndrome


This invention relates to a Chinese herbal medicine composition, its extract and application, which can effectually treat the symptoms of Irritable bowel syndrome (IBS). The composition is made from various kinds of important and effective Chinese herbal medicines and its extract is formulated as powders and suspensions.

  • Chinese Medicine for Prevention and Treatment of Irritable Bowel Syndrome 0
  • Chinese Medicine for Prevention and Treatment of Irritable Bowel Syndrome 1
Commercialisation opportunities
Collaboration and partnership for clinical trials
Problem addressed

IBS is a functional gastrointestinal disorder that there is no cure for it currently. The symptoms can be chronic or occasional and are without morphological and biochemical abnormality. The traditional chemical medications (e.g. Lubiprostone and Alosetron) are commonly used to relieve the symptoms. However, these medicines have strong side effects. Our herbal formula may provide hope to IBS sufferers.

  • The results have showed the invented Chinese herbal medicine composition can effectively cure visceral pain induced by rectal distension, torso pain induced by hot plate, diarrhea induced by castor oil and senna leaves.
  • The composition can soothe the pain or discomfort caused by IBS. Experiment shown that this composition has better results than placebo and any other compared medicine.
Key impact
  • IBS is a common functional gastrointestinal disorder which affects around 10 to 20% of people worldwide. Currently, there is no treatment or drug which can effectively cure the disorder, this invention may provide an additional effective therapy option for patients.
  • Gold Medal with Congratulations of Jury at the 46th International Exhibition of Inventions of Geneva 2018
  • The invention may be used to treat Irritable bowel syndrome (IBS) or other symptoms caused by functional gastrointestinal disorder including: abdominal pain, diarrhea, constipation, flatus, bloating and tenesmus.


  • China Patent No. ZL 200610146331.1
  • Hong Kong Patent No. HK 1118014
Hong Kong Baptist University (HKBU)

Aspiring to be a leading, research-led, liberal arts University in Asia, Hong Kong Baptist University is committed to conducting world-leading investigations that extends the frontiers of knowledge, tackles global challenges and benefits the community at home and abroad. 

Pursuing research excellence is one of the priorities of the University’s Institutional Strategic Plan 2018-2028. The University keeps enhancing its capacity and strength to produce world-class research with an aim to bring significant impact to the society.